Literature DB >> 33913677

Implementation of Distance-Based Simulation Training Programs for Healthcare Professionals: Breaking Barriers During COVID-19 Pandemic.

Magdalena Vera1, Eduardo Kattan, Tomas Cerda, Jessie Niklitshek, Rodrigo Montaña, Julian Varas, Marcia A Corvetto.   

Abstract

SUMMARY STATEMENT: The sudden rise of critically ill patients secondary to the SARS-CoV-2 pandemic has triggered a surge in healthcare response. This project's goal was to provide essential cognitive and technical skills to healthcare professionals returning to the workforce or reassigned to critical care clinical duties during the COVID-19 pandemic. The plan included the implementation of 4 distance-based simulation training programs, with asynchronous personalized feedback. The courses allowed the acquisition of skills for the complete critical care patient management chain: use of personal protection equipment, use of a high-flow nasal cannula, endotracheal intubation, and prone positioning. Participants logged into the platform, reviewed material, practiced while recording the session, and uploaded the video through the training platform. The expert tutor remotely delivered asynchronous feedback. Participants trained remotely until achieving course approval. Remote-based simulation seems a feasible and attractive alternative to provide adequate educational solutions, especially for remote and rural areas.
Copyright © 2021 Society for Simulation in Healthcare.

Entities:  

Mesh:

Year:  2021        PMID: 33913677     DOI: 10.1097/SIH.0000000000000550

Source DB:  PubMed          Journal:  Simul Healthc        ISSN: 1559-2332            Impact factor:   1.929


  1 in total

1.  A new approach for the acquisition of trauma surgical skills: an OSCE type of simulation training program.

Authors:  Catalina Ortiz; Javier Vela; Caterina Contreras; Francisca Belmar; Ivan Paul; Analia Zinco; Juan Pablo Ramos; Pablo Ottolino; Pablo Achurra; Nicolas Jarufe; Adnan Alseidi; Julian Varas
Journal:  Surg Endosc       Date:  2022-03-02       Impact factor: 4.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.